drug

KLS-2031

Phase 2updated 3mo ago

by Kolon Life Science Inc

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying KLS-2031

phase2Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathycompletedn=18
—A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Studyactive not recruitingn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

KLS-2031

Phase 2updated 3mo ago

by Kolon Life Science Inc

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying KLS-2031

phase2Single Ascending Doses Study of KLS-2031 in Subjects With Neuropathic Pain From Lumbosacral Radiculopathycompletedn=18
—A Long-term, 3-Year, Follow-up Study for Patients Completing the KS-GIG-001-01 Studyactive not recruitingn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

KLS-2031

all catalysts(0)

Trials studying KLS-2031

News(0)

Report a data issue

comments(0)

KLS-2031

all catalysts(0)

Trials studying KLS-2031

News(0)

Report a data issue

comments(0)